“Arguably one of the most promising pharmaceutical technologies of the past few years, LNPs may unlock better treatments for many diseases. This conference underlines the importance of their safe development and clinical translation in service of patients.”

Dimitrios Bitounis, Scientist, Investigative Toxicology, Sanofi - 2024 Expert Speaker

“LNP's stand to be a critical platform to deliver critical therapeutics to address unmet medical needs and understanding undesired immune responses is critical to ensure safe and effective treatments. This meeting provides the opportunity to share information across industry to enable better learning, understanding, and ultimately delivery of effective medicines.“

Jason Pennucci, Director, Bioanalytical Sciences, Moderna - 2024 Expert Speaker

“From what I know, every company involved in gene and cell therapies is currently using or has plans to use the LNP platform to deliver their therapeutic payloads. LNPs usually have inherent immunogenicity and toxicity. Therefore, it is crucial to address these issues in order to pave the way for the application of these new therapies to patients. This conference provides a platform for the industry to discuss latest advancements in the relevant subjects.”

Bin Wu, Founder & President, Cytodigm – 2024 Expert Speaker

“There are quite some progress in non-viral delivery of nucleic acids in recent years. However, to make such a delivery platform suitable and safe to more applications require better understanding of the mechanism and minimization of unwanted side effects. I am looking forward to hearing new progress in this aspect and sharing experience from scientists of different organizations.”

Liping Zhou, Senior Director, Advanced Drug Delivery, AstraZeneca - 2024 Expert Speaker